Control of Graves’ hyperthyroidism with very long-term methimazole treatment: a clinical trial
Abstract Background Long-term antithyroid drug therapy has become one of the options for treatment of Graves’ hyperthyroidism. The aim of this study was to compare thyroid status in those who discontinued methimazole (MMI) treatment after 12.8 years with those who continued MMI as long as 24 years....
Main Authors: | Fereidoun Azizi, Hengameh Abdi, Atieh Amouzegar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | BMC Endocrine Disorders |
Online Access: | https://doi.org/10.1186/s12902-020-00670-w |
Similar Items
-
Efficacy of low-dose methimazole in control of multiple relapses of Graves’ hyperthyroidism: a case report
by: Fereidoun Azizi, et al.
Published: (2021-04-01) -
Efficacy and Safety of Long-Term Methimazole versus Radioactive Iodine in the Treatment of Toxic Multinodular Goiter
by: Fereidoun Azizi, et al.
Published: (2022-12-01) -
Long-term methimazole therapy in Graves’ hyperthyroidism and adverse reactions: a Danish multicenter study
by: J Karmisholt, et al.
Published: (2023-01-01) -
Cholestasis and Acute Cholecystitis in Hyperthyroidism Treated With Methimazole
by: Wei-Che Chen, et al.
Published: (2009-12-01) -
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment
by: Daniela Gallo, et al.
Published: (2022-06-01)